Clinical Trials in Bath, Avon

A 32-week Trial to Evaluate the Efficacy and Safety of Tralokinumab in Subjects With Moderate-to-severe Atopic Hand Eczema Who Are Candidates for Systemic Therapy

NCT ID: NCT05958407

This clinical trial is studying a treatment called tralokinumab for people with moderate-to-severe atopic hand eczema, a skin condition that causes dry, itchy, and inflamed skin on the hands. The g...